Interactive Video Lecture
Critical Strategies and Approaches to Improve Outcomes in Heart Failure
Release Date: August 31, 2021
Expiration Date: August 30, 2022
CE/CME Credit Hours: 1.00
Pharmacology Credit Hours: 1.00
Begin »
program overview
Program Description
Heart failure (HF) is quite prevalent in the United States, and management is often complicated by the need to determine the patient's stage and functional classification, a complex set of guideline-directed therapies and dosing regimens, comorbid conditions, and patient adherence. In 2021, the American College of Cardiology updated its guidelines to address treatment options in HF—including information on treatment sequencing and the use of different drug classes in HF. In this activity, an expert in HF discusses how to apply this information in practice, with a focus on recognizing that patients and their caregivers frequently “adapt” to their HF regimens rather than simply adhering to them.
Format
Interactive video lecture
Learning Objectives
After completing this activity, participants should be better able to:
- Formulate treatment plans for patients with HF based on current recommendations
- Identify strategies to improve the transition of care from hospital to community in patients with HF
- Apply strategies to improve patient engagement of care in HF and ultimately reduce readmissions, morbidity, and mortality
Target Audience
NPs and PAs
Faculty
Lee R. Goldberg, MD, MPH
- Professor of Medicine
- Division of Cardiovascular Medicine
- Vice Chair of Medicine
- Section Chief
- Advanced Heart Failure and Cardiac Transplant
- Perelman School of Medicine
- University of Pennsylvania
- Philadelphia, Pennsylvania
Mary Knudtson, DNSc, NP, FAAN
- Professor of Clinical Nursing
- University of California, Irvine
- Irvine, California
- Nurse Practitioner
- JumpstartMD
- Walnut Creek, California
Details
Joint Accreditation Statement
In support of improving patient care, Practicing Clinicians Exchange is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
ANCC Credit Designation
Nursing contact hours: 1.00, which includes 1.00 hour of pharmacology credit
NP Course Advisor: Susan Tiso, DNP, FNP-BC, University of California, Irvine, Irvine, California
AAPA Credit Designation
Practicing Clinicians Exchange has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credit. Approval is valid until August 30, 2022. PAs should only claim credit commensurate with the extent of their participation.
PA course advisor: Lawrence Herman, DMSc, MPA, PA-C, University of Lynchburg, Lynchburg, Virginia
IPCE Credit Designation
This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.
This program was cosupported by educational grants from AbbVie Inc.; Amgen; Genentech, a member of the Roche Group; Incyte; and Merck.
This activity is supported by an educational grant from Merck.
The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Practicing Clinicians Exchange or any educational supporter.
All faculty and planners participating in continuing education activities sponsored by Practicing Clinicians Exchange (PCE) are required to disclose to the audience all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PCE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
Dr Goldberg: consulting fees: Abbott; consulting fees/research support: Respicardia.
Dr Herman: fees for non-CME/CE services: Novo Nordisk.
Dr Knudtson has no relevant financial relationships to disclose.
None of the members of the Planning Committee or PCE staff have any relevant relationships to disclose, except Dr Herman as noted above.
Participants wishing to earn CE/CME credit must:
- View the content in its entirety
- Relate the content material to the learning objectives
- Complete the post-test and evaluation form
Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of at least 67%.
The estimated time to complete this activity is 1.00 hour.
Release date: August 31, 2021
Expiration date: August 30, 2022
For Practicing Clinicians Exchange general information, contact pce@practicingclinicians.com.
© 2021 Practicing Clinicians Exchange. All Rights Reserved. 102121C-7B